AAF
Andra AP-fonden’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.25M | Sell |
6,900
-9,900
| -59% | -$3.23M | 0.03% | 340 |
|
2025
Q1 | $4.54M | Sell |
16,800
-11,100
| -40% | -$3M | 0.07% | 293 |
|
2024
Q4 | $6.57M | Buy |
27,900
+15,200
| +120% | +$3.58M | 0.11% | 265 |
|
2024
Q3 | $3.49M | Buy |
12,700
+9,600
| +310% | +$2.64M | 0.05% | 333 |
|
2024
Q2 | $753K | Buy |
+3,100
| New | +$753K | 0.01% | 377 |
|
2024
Q1 | – | Sell |
-35,500
| Closed | -$6.8M | – | 368 |
|
2023
Q4 | $6.8M | Buy |
35,500
+1,000
| +3% | +$191K | 0.36% | 132 |
|
2023
Q3 | $6.11M | Sell |
34,500
-6,000
| -15% | -$1.06M | 0.36% | 127 |
|
2023
Q2 | $7.69M | Sell |
40,500
-4,700
| -10% | -$893K | 0.19% | 214 |
|
2023
Q1 | $9.05M | Sell |
45,200
-10,400
| -19% | -$2.08M | 0.24% | 147 |
|
2022
Q4 | $13.2M | Buy |
55,600
+7,000
| +14% | +$1.66M | 0.4% | 19 |
|
2022
Q3 | $9.73M | Buy |
48,600
+6,500
| +15% | +$1.3M | 0.32% | 58 |
|
2022
Q2 | $6.14M | Buy |
+42,100
| New | +$6.14M | 0.18% | 256 |
|
2021
Q4 | $4.82M | Buy |
28,400
+8,500
| +43% | +$1.44M | 0.1% | 419 |
|
2021
Q3 | $3.76M | Buy |
19,900
+2,500
| +14% | +$472K | 0.08% | 488 |
|
2021
Q2 | $2.95M | Buy |
17,400
+1,400
| +9% | +$237K | 0.06% | 532 |
|
2021
Q1 | $2.26M | Sell |
16,000
-2,500
| -14% | -$353K | 0.05% | 537 |
|
2020
Q4 | $2.4M | Buy |
18,500
+4,300
| +30% | +$559K | 0.05% | 552 |
|
2020
Q3 | $2.07M | Sell |
14,200
-23,900
| -63% | -$3.48M | 0.06% | 562 |
|
2020
Q2 | $5.64M | Buy |
38,100
+3,700
| +11% | +$548K | 0.16% | 280 |
|
2020
Q1 | $3.74M | Buy |
34,400
+20,000
| +139% | +$2.18M | 0.14% | 388 |
|
2019
Q4 | $1.66M | Buy |
14,400
+11,600
| +414% | +$1.34M | 0.05% | 626 |
|
2019
Q3 | $225K | Buy |
+2,800
| New | +$225K | 0.01% | 657 |
|
2019
Q2 | – | Sell |
-5,600
| Closed | -$523K | – | 658 |
|
2019
Q1 | $523K | Buy |
+5,600
| New | +$523K | 0.02% | 635 |
|
2018
Q3 | – | Sell |
-12,800
| Closed | -$1.26M | – | 637 |
|
2018
Q2 | $1.26M | Sell |
12,800
-1,900
| -13% | -$187K | 0.03% | 623 |
|
2018
Q1 | $1.75M | Buy |
14,700
+12,800
| +674% | +$1.52M | 0.05% | 622 |
|
2017
Q4 | $241K | Buy |
+1,900
| New | +$241K | 0.01% | 672 |
|